Bone metastasis is associated with poor survival rates and a markedly reduced quality of life. Osteocytes, the most abundant cells in bone, are essential for maintaining bone structure and ...

After snapping a few photos, some of which included their goldendoodle who wore a handkerchief that read, “Mint to be,” ...

Samsung Bioepis’ biosimilars Ospomyv and Xbryk have been approved to be interchangeable with Prolia/Xgeva treat osteoporosis and multiple myeloma/bone metastases from solid tumors.

Ospomyv, a biosimilar to Prolia, is indicated for postmenopausal women and men at high risk of fracture, while Xbryk, a ...

A recent study has uncovered the molecular mechanisms behind osteocyte death in melanoma bone metastasis, revealing that ferroptosis—an iron-dependent form of cell death—plays a central role ...

Radium-223 re-treatment is safe for metastatic castration-resistant prostate cancer, per findings from the 2025 ASCO GU ...

Aston University is collaborating in research to develop an injectable paste which could treat bone cancer. The Royal ...

Aston University is collaborating in research to develop an injectable paste which could treat bone cancer.

Metastatic breast cancer affects people in many ways. The symptoms experienced by each person will vary based on the parts of the body that are affected. Some symptoms are a result of the cancer, and ...

Zoledronic acid is a potent, new-generation bisphosphonate indicated for the treatment of documented bone metastasis in patients with solid tumors and bone lesions associated with multiple myeloma.

An ‘all clear’ at the end of treatment doesn’t necessarily mean the end of cancer. But new UK research aims to eliminate the ...